Calidi Biotherapeutics (NYSE American: CLDI) announced the successful closing of a public offering of 4,437,869 shares of common stock at $1.69 per share, raising approximately $7.5 million in gross proceeds....
Calidi Biotherapeutics (NYSE American: CLDI) presented data at the International Oncolytic Virotherapy Conference and the Society for Immunotherapy of Cancer Annual Meeting highlighting its RTNova systemic...
Calidi Biotherapeutics closed a public offering of approximately 4.4 million shares, raising $7.5 million for its cancer therapies.Quiver AI SummaryCalidi Biotherapeutics Inc. has successfully closed a...
Calidi Biotherapeutics (NYSE American: CLDI) has announced plans to sell shares of its common stock and/or pre-funded warrants in a public offering with Ladenburg Thalmann & Co. Inc. as the exclusive placement...
Calidi Biotherapeutics plans to offer shares of common stock to fund working capital and corporate purposes.Quiver AI SummaryCalidi Biotherapeutics, Inc. announced its intention to conduct a public offering...